Crawford expected stay on as permanent FDA commissioner

The White House appears to have selected FDA acting commissioner Lester Crawford as its choice to fill the position on a permanent basis, The Pink Sheet reported this week.
News of the selection came after Crawford reportedly met with President Bush on Jan. 27 – a move considered by Beltway insiders as an indication that a decision has been made and an announcement could come at any time.
Crawford has been acting commissioner since Mark McClellan left the FDA to take the over the Centers for Medicare & Medicaid Services in March.
If Crawford is the nominee, he would become the first to move up from the acting role to fully confirmed position.
You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.